About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
American Journal of Therapeutics
›
Top Articles
American Journal of Therapeutics
Pharmacology
1
(top 16%)
Impact Factor
1.1
(top 16%)
extended IF
62
(top 6%)
H-Index
630
authors
3.2K
papers
31.2K
citations
5.2K
citing journals
21K
citing authors
Most Cited Articles of American Journal of Therapeutics
Title
Year
Citations
Mechanism of action of paracetamol
2005
384
Opioid therapy and immunosuppression: a review
2004
298
Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
2001
269
Methylene blue
2003
246
Autoimmune destruction of pancreatic beta cells
2005
218
Meperidine: a critical review
2002
183
Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System
2000
151
Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia
2001
148
Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit
2006
144
Immunomodulation and blood transfusion
2002
144
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor
2000
137
Confounding by indication in epidemiologic studies of commonly used analgesics
2002
134
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
2005
127
Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics
2000
123
In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity
2004
118
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty
2002
114
Advances in the treatment of type 2 diabetes mellitus
2011
112
The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey
2008
112
Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals
2003
111
QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs
2003
111
Comorbidity of irritable bowel syndrome in psychiatric patients: a review
2003
105
Effects of modern ski equipment on the overall injury rate and the pattern of injury location in Alpine skiing
2008
102
Assessing the impact of protocol design changes on clinical trial performance
2008
102
Antimicrobial properties of honey
2014
101
Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia
2007
100
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.